HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and evaluation of antitumor activity of novel 2-[Nmethyl-N-(4-methyl-1,3-benzothiazol-2-yl)aminomethyl]-5,8-diacyloxy-1,4-naphthoquinones.

Abstract
A series of nine new compounds bridged by acyl groups at the 5,8-dihydroxyl group of DHNQ were synthesized and their cytotoxic activity against L1210 and P388 cancer cells was examined. Their antitumor action in mice bearing S-180 cells in the peritoneal cavity was also assessed. Increasing the size of the acyl group (compounds 7-9) up to propyl increased the antitumor activity (T/C value), whereas the cytotoxicity of these compounds was comparable against L1210 (lymphocytic leukemia) and P388 (lymphoid neoplasm) cancer cells. Further increasing in the chain length (compounds 11-15) decreased the potency. Thus, acyl group chains of three carbon atoms is optimal for antitumor activity. The most potent compound of this series was 2-[N-methyl-N-(4-methyl-1,3-benzothiazol-2-yl)aminomethyl]-5,8-dipropylcarbonyloxy-1,4-naphthoquinone (compound 9) with a T/C (%) value of 354.
AuthorsJikang Yoo, Hyun-Suk Choi, Cheol-Hee Choi, Yongseog Chung, Bok Hee Kim, Hoon Cho
JournalArchives of pharmacal research (Arch Pharm Res) Vol. 31 Issue 2 Pg. 142-7 (Feb 2008) ISSN: 0253-6269 [Print] Korea (South)
PMID18365681 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Naphthoquinones
  • Tetrazolium Salts
  • Thiazoles
  • thiazolyl blue
Topics
  • Animals
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Drug Screening Assays, Antitumor
  • Leukemia L1210 (drug therapy)
  • Leukemia P388 (drug therapy)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Naphthoquinones (chemical synthesis, pharmacology)
  • Neoplasm Transplantation
  • Sarcoma 180 (drug therapy)
  • Structure-Activity Relationship
  • Tetrazolium Salts
  • Thiazoles

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: